Assurgen Pharma Private Limited - Due diligence report

A 360° intelligence report on Assurgen Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signal…

2013-10-10 Visakhapatnam, Andhra Pradesh Active Unlisted Active Compliant
Share
Connect MCP
AP Assurgen Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Assurgen Pharma — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Assurgen Pharma is assessed as Moderate with a Trust Score of 72/100. Assurgen Pharma is an active private limited indian non-government company incorporated in 2013, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Aug 2026 from the latest processed filings. Assurgen Pharma Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 1 open (23.50 cr) · 4 satisfied (23.29 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Andhra Pradesh State Financial Corporation.1 48.0 cr
Others3 48.0 cr
Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
NAVEEN PARUPALLI 01234567 Director 01/04/2018 6 yrs Approved
PAIDI LAKSHMAN RAO 01234567 Director 01/04/2018 6 yrs Approved
SRINIVASA RAO VAYETLA 01234567 Director 01/04/2018 6 yrs Approved
JOHANN DANKLMAIER 01234567 Director 01/04/2018 6 yrs Approved
RAVI KUMAR POTLURI 01234567 Director 01/04/2018 6 yrs Approved
ISHAK ALI MOHAMMED 01234567 Director 01/04/2018 6 yrs Approved
NAGENDRA RAO KUKALAKUNTA 01234567 Director 01/04/2018 6 yrs Approved
DR GEORG STARK 01234567 Director 01/04/2018 6 yrs Approved
Srinivas Nimmagadda 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • PAIDI LAKSHMAN RAO has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
24 allotment(s) · 5 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: NAGENDRA RAO KUKALAKUNTA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 23.50 cr already registered.
  • Compliance record supports lending.
Investor view70/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
JOHANN DANKLMAIER
12 Sep 2024
Director appointed
Srinivas Nimmagadda (Company Secretary)
02 Jul 2024
Director appointed
JOHANN DANKLMAIER (Director)
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Mar 2024
Director ceased
PAIDI LAKSHMAN RAO
15 Jun 2022
Securities allotted
12975000 Equity Shares - 12.98 cr raised
17 Mar 2022
Director appointed
ISHAK ALI MOHAMMED (Company Secretary)
04 Jan 2022
Charge satisfied
Others
Charge satisfied
Andhra Pradesh State Financial Corporation.
30 Oct 2021
Charge created
Hdfc Bank Limited - 23.50 cr
31 Mar 2021
Share transfer (FY 2021)
100000.00000000 shares to LAKSHMAN RAO PAIDI
Share transfer (FY 2021)
2000000.00000000 shares to HEMALATHA PARUPALLI
Share transfer (FY 2021)
2030000.00000000 shares to CHANDRAMATHI PAIDI
01 Dec 2020
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
9 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 24 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Varahi Pharma Private Limited U24297TG2010PTC066811 Hyderabad, Telangana, India
Agro India Gums Private Limited U01122RJ2008PTC026630 Jodhpur, Rajasthan, India
Eskay Herbal Formulations Private Limited U85191MH2008PTC186746 Jalgaon, Maharashtra, India
Bhagyalaxmi Brinechem Private Limited U24100RJ2012PTC039716 Nawa City, Rajasthan, India
Amara Labs Private Limited U36990TG2016PTC113244 Hyderabad, Telangana, India
Omkarchemicals L24110MH2005PLC151589 Badlapur, Maharashtra, India
Ezhil Chemical U24294TN1988PTC016660 Nagapattinam, Tamil Nadu, India
Chopra Strips Limited U27104RJ2003PLC065276 Jodhpur, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Assurgen Pharma before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Assurgen Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Assurgen Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Assurgen Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Assurgen Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Assurgen Pharma an active company?

Assurgen Pharma has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Assurgen Pharma financially healthy?

Assurgen Pharma has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Assurgen Pharma?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Assurgen Pharma?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 9 active director(s) are on record.

Does Assurgen Pharma have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Assurgen Pharma up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Assurgen Pharma?

Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.